Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$373K Sell
10,271
-45
-0.4% -$1.67K ﹤0.01% 1071
2025
Q4
$322K Buy
+10,316
New +$319K ﹤0.01% 1110
2025
Q1
$390K Buy
10,503
+625
+6% +$25.8K ﹤0.01% 989
2024
Q4
$404K Buy
9,878
+1,794
+22% +$86.9K ﹤0.01% 1009
2024
Q3
$407K Buy
8,084
+2,335
+41% +$107K ﹤0.01% 1005
2024
Q2
$251K Buy
5,749
+805
+16% +$35.2K ﹤0.01% 1109
2024
Q1
$215K Buy
+4,944
New +$193K ﹤0.01% 1164
2020
Q4
Sell
-522
Closed -$13K 1290
2020
Q3
$13K Sell
522
-16,792
-97% -$438K ﹤0.01% 1767
2020
Q2
$453K Buy
17,314
+16,999
+5,397% +$395K ﹤0.01% 790
2020
Q1
$10K Hold
315
﹤0.01% 2414
2019
Q4
$10K Sell
315
-57,152
-99% -$1.87M ﹤0.01% 2414
2019
Q3
$1.88K Buy
57,467
+265
+0.5% +$8.4K 0.01% 629
2019
Q2
$1.79K Sell
57,202
-260
-0.5% -$7.28K 0.01% 646
2019
Q1
$1.68K Sell
57,462
-25
-0% -$785 0.01% 664
2018
Q4
$1.64K Sell
57,487
-411
-0.7% -$13.8K 0.01% 650
2018
Q3
$2.53M Buy
57,898
+3
+0% +$131 0.01% 605
2018
Q2
$2.5M Buy
57,895
+57,152
+7,692% +$2.46M 0.01% 577
2018
Q1
$32K Hold
743
﹤0.01% 1793
2017
Q4
$32K Sell
743
-5,941
-89% -$261K ﹤0.01% 1793
2017
Q3
$267K Sell
6,684
-10,268
-61% -$383K ﹤0.01% 1116
2017
Q2
$577K Hold
16,952
﹤0.01% 906
2017
Q1
$577K Buy
16,952
+7,408
+78% +$248K ﹤0.01% 906
2016
Q4
$305K Buy
9,544
+9,169
+2,445% +$295K ﹤0.01% 1086
2016
Q3
$12K Sell
375
-10
-3% -$346 ﹤0.01% 2088
2016
Q2
$13K Hold
385
﹤0.01% 2035
2016
Q1
$11K Hold
385
﹤0.01% 2010
2015
Q4
$11K Buy
385
+25
+7% +$836 ﹤0.01% 2036
2015
Q3
$10K Sell
360
-190,693
-100% -$6.44M ﹤0.01% 2110
2015
Q2
$7.48M Buy
191,053
+9,216
+5% +$360K 0.05% 381
2015
Q1
$6.79M Buy
181,837
+11,040
+6% +$419K 0.05% 395
2014
Q4
$6.47M Sell
170,797
-42,082
-20% -$1.54M 0.05% 398
2014
Q3
$7.57M Buy
212,879
+212,719
+132,949% +$8.36M 0.07% 354
2014
Q2
$6K Buy
160
+110
+220% +$4.3K ﹤0.01% 2124
2014
Q1
$1K Hold
50
﹤0.01% 2280
2013
Q4
$1K Hold
50
﹤0.01% 2242
2013
Q3
$1K Buy
+50
New +$1.41K ﹤0.01% 2171

Other funds holding AVNT

Glenmede Trust's AVNT Position: Q1 2026 in Review

Glenmede Trust reduced its Avient (AVNT) stake by 0.44% in Q1 2026, selling an estimated $1.67K and leaving 10,271 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #1071.

Glenmede Trust first reported a position in AVNT in Q3 2013 and has held it in 36 quarters since. The position peaked at $7.57M in Q3 2014. 342 funds tracked by Wall St. Rank hold AVNT as of Q1 2026.

  • Glenmede Trust held 10,271 shares of Avient worth $373K as of Q1 2026.
  • Glenmede Trust sold 45 Avient shares in Q1 2026, an estimated $1.67K.
  • Avient made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1071 holding.
  • Glenmede Trust first reported a position in Avient in Q3 2013 and has held it in 36 quarters since.
  • Glenmede Trust's Avient position peaked at $7.57M in Q3 2014.
  • 342 funds tracked by Wall St. Rank held Avient as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.